BiotechTube
Amped PCR

Amped PCR

Cambridge, United Kingdom· Est.
ampedpcr.co.uk
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Amped PCR is an innovative Cambridge-based biotech focused on disrupting the PCR reagents market with its ambient-stable, high-performance formulations. The company has secured early-stage investment and grant funding to develop its core reagent business and an AI-driven data analytics platform called PurifAI. With a lean, founder-led team, Amped PCR is positioned to capture market share by addressing key pain points in the supply chain and offering flexible, high-sensitivity products to research and diagnostic partners.

Diagnostics

Technology Platform

Proprietary formulations for ambient-stable, high-performance PCR mastermixes and reagents. Also developing an AI-driven data analytics platform (PurifAI) for assay optimisation.

Opportunities

The global push for sustainable, low-logistics solutions in life sciences creates a major opportunity for their ambient-stable reagents.
Expansion into custom OEM/white-label deals with diagnostic and applied testing companies offers a high-margin, scalable revenue channel.

Risk Factors

Facing intense competition from entrenched market leaders with vast resources and sales reach.
Scaling manufacturing and global distribution as a small startup presents significant operational and financial challenges.

Competitive Landscape

Competes directly with large, established life science tools companies like Thermo Fisher Scientific, Bio-Rad, and Qiagen in the PCR reagents market. Its differentiation is based on ambient stability, performance claims, and customisation flexibility, rather than competing on breadth of product portfolio.

More companies in Diagnostics & Precision Medicine →More companies in United Kingdom →